SG Americas Securities’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-89,023
| Closed | -$171K | – | 2516 |
|
2025
Q1 | $171K | Sell |
89,023
-27,748
| -24% | -$53.3K | ﹤0.01% | 2357 |
|
2024
Q4 | $222K | Buy |
116,771
+44,806
| +62% | +$85.2K | ﹤0.01% | 1812 |
|
2024
Q3 | $95K | Buy |
71,965
+38,821
| +117% | +$51.2K | ﹤0.01% | 2753 |
|
2024
Q2 | $34K | Buy |
+33,144
| New | +$34K | ﹤0.01% | 2349 |
|
2022
Q1 | – | Sell |
-43,176
| Closed | -$98K | – | 2553 |
|
2021
Q4 | $98K | Sell |
43,176
-68,084
| -61% | -$155K | ﹤0.01% | 2790 |
|
2021
Q3 | $320K | Buy |
111,260
+98,423
| +767% | +$283K | ﹤0.01% | 2647 |
|
2021
Q2 | $49K | Sell |
12,837
-18,080
| -58% | -$69K | ﹤0.01% | 2459 |
|
2021
Q1 | $105K | Buy |
30,917
+12,421
| +67% | +$42.2K | ﹤0.01% | 2783 |
|
2020
Q4 | $52K | Sell |
18,496
-214,366
| -92% | -$603K | ﹤0.01% | 2737 |
|
2020
Q3 | $584K | Buy |
232,862
+178,717
| +330% | +$448K | ﹤0.01% | 1277 |
|
2020
Q2 | $735K | Buy |
54,145
+19,275
| +55% | +$262K | 0.01% | 1458 |
|
2020
Q1 | $264K | Buy |
34,870
+9,734
| +39% | +$73.7K | ﹤0.01% | 1941 |
|
2019
Q4 | $159K | Buy |
25,136
+10,674
| +74% | +$67.5K | ﹤0.01% | 2280 |
|
2019
Q3 | $57K | Buy |
+14,462
| New | +$57K | ﹤0.01% | 2377 |
|
2019
Q2 | – | Sell |
-26,797
| Closed | -$219K | – | 2518 |
|
2019
Q1 | $219K | Sell |
26,797
-52,227
| -66% | -$427K | ﹤0.01% | 2189 |
|
2018
Q4 | $437K | Sell |
79,024
-605
| -0.8% | -$3.35K | ﹤0.01% | 1677 |
|
2018
Q3 | $703K | Buy |
+79,629
| New | +$703K | 0.01% | 1731 |
|
2017
Q4 | – | Sell |
-8,650
| Closed | -$170K | – | 2514 |
|
2017
Q3 | $170K | Sell |
8,650
-534
| -6% | -$10.5K | ﹤0.01% | 2370 |
|
2017
Q2 | $132K | Buy |
+9,184
| New | +$132K | ﹤0.01% | 2379 |
|
2017
Q1 | – | Sell |
-14,852
| Closed | -$155K | – | 2774 |
|
2016
Q4 | $155K | Buy |
+14,852
| New | +$155K | ﹤0.01% | 2249 |
|
2016
Q2 | – | Sell |
-10,096
| Closed | -$91K | – | 2112 |
|
2016
Q1 | $91K | Buy |
+10,096
| New | +$91K | ﹤0.01% | 2322 |
|